Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Red blood cells: The metamorphosis of a neglected carrier into the natural mothership for artificial nanocarriers
Patrick M. Glassman, Elizabeth D. Hood, Laura T. Ferguson, et al.
Advanced Drug Delivery Reviews (2021) Vol. 178, pp. 113992-113992
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Unlocking the promise of mRNA therapeutics
Eduarde Rohner, Ran Yang, Kylie S. Foo, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 11, pp. 1586-1600
Open Access | Times Cited: 266
Microenvironment-driven sequential ferroptosis, photodynamic therapy, and chemotherapy for targeted breast cancer therapy by a cancer-cell-membrane-coated nanoscale metal-organic framework
Weilun Pan, Yong Tan, Wei Meng, et al.
Biomaterials (2022) Vol. 283, pp. 121449-121449
Closed Access | Times Cited: 146
Biomimetic Nano-Drug Delivery System: An Emerging Platform for Promoting Tumor Treatment
Xiujuan Han, Chunai Gong, Qingru Yang, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 571-608
Open Access | Times Cited: 26
Engineering cells for precision drug delivery: New advances, clinical translation, and emerging strategies
Chih-Jia Chao, Endong Zhang, Zongmin Zhao
Advanced Drug Delivery Reviews (2023) Vol. 197, pp. 114840-114840
Closed Access | Times Cited: 28
Messenger RNA-Based Therapeutics and Vaccines: What’s beyond COVID-19?
Dongqiao Li, Cynthia Liu, Yingzhu Li, et al.
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 7, pp. 943-969
Open Access | Times Cited: 22
Artificial cells for in vivo biomedical applications through red blood cell biomimicry
Jorik Waeterschoot, Willemien Gosselé, Špela Lemež, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
All-stage targeted red blood cell membrane-coated docetaxel nanocrystals for glioma treatment
Yuan Ding, Qianzhu Xu, Zhilan Chai, et al.
Journal of Controlled Release (2024) Vol. 369, pp. 325-334
Closed Access | Times Cited: 6
Nonviral targeted mRNA delivery: principles, progresses, and challenges
Xi He, Guohong Li, Li-Hsin Huang, et al.
MedComm (2025) Vol. 6, Iss. 1
Open Access
Flexible Morphological Regulation of Photothermal Nanodrugs: Understanding the Relationship between the Structure, Photothermal Effect, and Tumoral Biodistribution
Shukun Li, Yudong Li, Guizhi Shen, et al.
ACS Nano (2025)
Closed Access
Biomechanical and Functional Features of the Carrier Erythrocytes Prolonging Circulation Time of Biotherapeutic Targeted to Glycophorin A
Alina D. Peshkova, Taylor V. Brysgel, Parth Mody, et al.
Bioconjugate Chemistry (2025)
Closed Access
Hemolytic Activity of Nanoparticles as a Marker of Their Hemocompatibility
Saul Yedgar, Gregory Barshtein, Alexander Gural
Micromachines (2022) Vol. 13, Iss. 12, pp. 2091-2091
Open Access | Times Cited: 33
Red Blood Cell Inspired Strategies for Drug Delivery: Emerging Concepts and New Advances
Endong Zhang, Philana Phan, Hanan Ahmed Algarni, et al.
Pharmaceutical Research (2022) Vol. 39, Iss. 11, pp. 2673-2698
Closed Access | Times Cited: 28
Biomimetic approaches for targeting tumor-promoting inflammation
Alessandro Parodi, Dmitry Kostyushev, Sergey Brezgin, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 555-567
Closed Access | Times Cited: 26
Advances in Microfluidics for Single Red Blood Cell Analysis
Georgii V. Grigorev, А. И. Лебедев, Xiaohao Wang, et al.
Biosensors (2023) Vol. 13, Iss. 1, pp. 117-117
Open Access | Times Cited: 18
Advances in treatment strategies based on scavenging reactive oxygen species of nanoparticles for atherosclerosis
Chengxi Wu, Jingying Mao, Xueqin Wang, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 18
Cancer Cell-Mimicking Prussian Blue Nanoplatform for Synergistic Mild Photothermal/Chemotherapy via Heat Shock Protein Inhibition
Yun Wang, Jinling Wang, Roumei Ye, et al.
ACS Applied Materials & Interfaces (2024)
Closed Access | Times Cited: 4
Manipulate tumor hypoxia for improved photodynamic therapy using nanomaterials
Mengqi Yi, Bei Xiong, Yuyang Li, et al.
European Journal of Medicinal Chemistry (2022) Vol. 247, pp. 115084-115084
Closed Access | Times Cited: 23
Nature-inspired nanocarriers for improving drug therapy of atherosclerosis
Weihong Ji, Yuanxing Zhang, Yuanru Deng, et al.
Regenerative Biomaterials (2023) Vol. 10
Open Access | Times Cited: 14
Maleimide as the PEG end-group promotes macrophage-targeted drug delivery of PEGylated nanoparticles in vivo by enhancing interaction with circulating erythrocytes
Xin Wang, Xiandi Meng, Kuirong Mao, et al.
Biomaterials (2023) Vol. 300, pp. 122187-122187
Closed Access | Times Cited: 13
Biomembrane nanostructures: Multifunctional platform to enhance tumor chemoimmunotherapy via effective drug delivery
Xianghe Jiang, Lili Wu, Mengya Zhang, et al.
Journal of Controlled Release (2023) Vol. 361, pp. 510-533
Closed Access | Times Cited: 13
Lipid-hybrid cell-derived biomimetic functional materials: A state-of-the-art multifunctional weapon against tumors
Wen-Shang Liu, Lili Wu, Cui-Min Chen, et al.
Materials Today Bio (2023) Vol. 22, pp. 100751-100751
Open Access | Times Cited: 12
Advanced hitchhiking nanomaterials for biomedical applications
Ying Wang, Shao‐Kai Sun, Yang Liu, et al.
Theranostics (2023) Vol. 13, Iss. 14, pp. 4781-4801
Open Access | Times Cited: 12
Antigen-specific immunotherapies in type 1 diabetes
Xuejiao Zhang, Ying Dong, Dianyuan Liu, et al.
Journal of Trace Elements in Medicine and Biology (2022) Vol. 73, pp. 127040-127040
Closed Access | Times Cited: 20
Cellular nanovesicles for therapeutic immunomodulation: A perspective on engineering strategies and new advances
Endong Zhang, Philana Phan, Zongmin Zhao
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 5, pp. 1789-1827
Open Access | Times Cited: 20
Targeted In Vivo Loading of Red Blood Cells Markedly Prolongs Nanocarrier Circulation
Patrick M. Glassman, Carlos H. Villa, Oscar A. Marcos‐Contreras, et al.
Bioconjugate Chemistry (2022) Vol. 33, Iss. 7, pp. 1286-1294
Closed Access | Times Cited: 19
Page 1 - Next Page

Scroll to top